{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:26:35Z","timestamp":1772166395516,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T00:00:00Z","timestamp":1576022400000},"content-version":"vor","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pragmatic trials have been suggested as a way to improve the relevance of clinical trial results to practice. PRECIS-2 (Pragmatic Explanatory Continuum Indicator Summary-2) is a trial design tool which considers how pragmatic a trial is across a number of domains. It is not known whether a pragmatic approach to all PRECIS-2 domains leads to results being more relevant to primary care. The aim of this study was to investigate the views of people with influence on primary care practice towards the design of randomised trials, pragmatic approaches to trial design, and the PRECIS-2 domains.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We carried out semi-structured interviews with people who influence practice in primary care in the UK. A thematic analysis was undertaken using the framework approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We conducted individual or small group interviews involving an elite sample of 17 individuals. We found that an exclusively pragmatic approach to randomised trials may not always make the results of trials more applicable to primary care. For example, it may be better to have less flexibility in the way interventions are delivered in randomised trials than in practice. In addition, an appropriate balance needs to be struck when thinking about levels of resourcing and the intensity of steps needed to improve adherence in a trial. Across other aspects of a trial\u2019s design, for example the population and trial setting, a pragmatic approach was viewed as more appropriate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>To maximize the relevance of research directed at primary care, trials should be conducted with the same populations and settings that are found in primary care. Across other aspects of trials it is not always necessary to match the conditions found in practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-019-3812-7","type":"journal-article","created":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T10:04:53Z","timestamp":1576058693000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Improving the relevance of randomised trials to primary care: a qualitative study investigating views towards pragmatic trials and the PRECIS-2 tool"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8662-3636","authenticated-orcid":false,"given":"Gordon","family":"Forbes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsty","family":"Loudon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Clinch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie J. C.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaun","family":"Treweek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Eldridge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,11]]},"reference":[{"issue":"6","key":"3812_CR1","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/fampra\/cmq099","volume":"27","author":"S Eldridge","year":"2010","unstructured":"Eldridge S. Pragmatic trials in primary health care: what, when and how? Fam Pract. 2010;27(6):591\u20132.","journal-title":"Fam Pract"},{"issue":"1","key":"3812_CR2","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1186\/s13063-015-1023-4","volume":"16","author":"T Kennedy-Martin","year":"2015","unstructured":"Kennedy-Martin T, Curtis S, Faries D, Robinson S, Johnston J. A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results. Trials. 2015;16(1):495.","journal-title":"Trials."},{"key":"3812_CR3","unstructured":"Smith J, Holder H, Edwards N, Maybin J, Parker H, Rosen R, Walsh N. Securing the future of general practice: new models of primary care. Research report. Nuffield Trust and King's Fund; 2013."},{"key":"3812_CR4","doi-asserted-by":"publisher","first-page":"a1655","DOI":"10.1136\/bmj.a1655","volume":"337","author":"P Craig","year":"2008","unstructured":"Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M, et al. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008;337:a1655 (Clinical research ed).","journal-title":"BMJ"},{"issue":"8","key":"3812_CR5","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/0021-9681(67)90041-0","volume":"20","author":"D Schwartz","year":"1967","unstructured":"Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutical trials. J Chronic Dis. 1967;20(8):637\u201348.","journal-title":"J Chronic Dis"},{"issue":"7127","key":"3812_CR6","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1136\/bmj.316.7127.285","volume":"316","author":"M Roland","year":"1998","unstructured":"Roland M, Torgerson DJ. What are pragmatic trials? BMJ. 1998;316(7127):285 (Clinical research ed).","journal-title":"BMJ"},{"issue":"4","key":"3812_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/ebm.14.4.101","volume":"14","author":"M Zwarenstein","year":"2009","unstructured":"Zwarenstein M, Treweek S. What kind of randomised trials do patients and clinicians need? Evid Based Med. 2009;14(4):101\u20133.","journal-title":"Evid Based Med"},{"key":"3812_CR8","doi-asserted-by":"publisher","first-page":"a2390","DOI":"10.1136\/bmj.a2390","volume":"337","author":"M Zwarenstein","year":"2008","unstructured":"Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B, et al. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ. 2008;337:a2390 (Clinical research ed).","journal-title":"BMJ"},{"issue":"12","key":"3812_CR9","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jama.290.12.1624","volume":"290","author":"SR Tunis","year":"2003","unstructured":"Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003;290(12):1624\u201332.","journal-title":"JAMA"},{"key":"3812_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1745-6215-10-37","volume":"10","author":"S Treweek","year":"2009","unstructured":"Treweek S, Zwarenstein M. Making trials matter: pragmatic and explanatory trials and the problem of applicability. Trials. 2009;10:37.","journal-title":"Trials."},{"key":"3812_CR11","unstructured":"NIHR. HTA: Is an intervention ready for HTA evaluation? 2019 [Version: v1.0 Aug 19:[Available from: https:\/\/www.nihr.ac.uk\/documents\/hta-is-an-intervention-ready-for-hta-evaluation\/22003?pr=. Accessed 10 Sept 2019."},{"issue":"1","key":"3812_CR12","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12874-017-0420-7","volume":"17","author":"KP Weinfurt","year":"2017","unstructured":"Weinfurt KP, Hernandez AF, Coronado GD, DeBar LL, Dember LM, Green BB, et al. Pragmatic clinical trials embedded in healthcare systems: generalizable lessons from the NIH Collaboratory. BMC Med Res Methodol. 2017;17(1):144.","journal-title":"BMC Med Res Methodol"},{"key":"3812_CR13","unstructured":"PCORI. Research we support [Available from: https:\/\/www.pcori.org\/research-results\/about-our-research\/research-we-support. Accessed 10 Sept 2019."},{"key":"3812_CR14","unstructured":"IMI GetReal - Real-Life Data In Drug Development 2016 [Available from: https:\/\/www.imi-getreal.eu\/. Accessed 9 Dec 2016."},{"key":"3812_CR15","doi-asserted-by":"publisher","first-page":"h2147","DOI":"10.1136\/bmj.h2147","volume":"350","author":"K Loudon","year":"2015","unstructured":"Loudon K, Treweek S, Sullivan F, Donnan P, Thorpe KE, Zwarenstein M. The PRECIS-2 tool: designing trials that are fit for purpose. BMJ. 2015;350:h2147 (Clinical research ed).","journal-title":"BMJ"},{"issue":"6","key":"3812_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002040","volume":"13","author":"SJ Taylor","year":"2016","unstructured":"Taylor SJ, Carnes D, Homer K, Kahan BC, Hounsome N, Eldridge S, et al. Novel three-day, community-based, nonpharmacological group intervention for chronic musculoskeletal pain (COPERS): A randomised clinical trial. PLoS Med. 2016;13(6):e1002040.","journal-title":"PLoS Med"},{"key":"3812_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jclinepi.2017.06.007","volume":"90","author":"G Forbes","year":"2017","unstructured":"Forbes G, Loudon K, Treweek S, Taylor SJC, Eldridge S. Understanding the applicability of results from primary care trials: lessons learned from applying PRECIS-2. J Clin Epidemiol. 2017;90:119\u201326.","journal-title":"J Clin Epidemiol"},{"key":"3812_CR18","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jclinepi.2017.10.015","volume":"93","author":"AE Jordan","year":"2018","unstructured":"Jordan AE, Perlman DC, Smith DJ, Reed JR, Hagan H. Use of the PRECIS-II instrument to categorize reports along the efficacy-effectiveness spectrum in an hepatitis C virus care continuum systematic review and meta-analysis. J Clin Epidemiol. 2018;93:66\u201375.","journal-title":"J Clin Epidemiol"},{"issue":"594","key":"3812_CR19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3399\/bjgp12X616238","volume":"62","author":"N Foster","year":"2012","unstructured":"Foster N, Little P. Methodological issues in pragmatic trials of complex interventions in primary care. Br J Gen Pract. 2012;62(594):10\u20131.","journal-title":"Br J Gen Pract"},{"key":"3812_CR20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1471-2288-3-28","volume":"3","author":"M Godwin","year":"2003","unstructured":"Godwin M, Ruhland L, Casson I, MacDonald S, Delva D, Birtwhistle R, et al. Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity. BMC Med Res Methodol. 2003;3:28.","journal-title":"BMC Med Res Methodol"},{"key":"3812_CR21","doi-asserted-by":"crossref","unstructured":"Ritchie J, Spencer L. Qualitative data analysis for applied policy research. In Huberman AM & Miles MB. The qualitative researcher's companion. Thousand Oaks, CA: SAGE Publications, Inc.; 2002. pp. 305\u2013329.","DOI":"10.4135\/9781412986274.n12"},{"key":"3812_CR22","unstructured":"NIHR. Excess treatment costs [Available from: https:\/\/www.nihr.ac.uk\/researchers\/collaborations-services-and-support-for-your-research\/run-your-study\/excess-treatment-costs.htm. Accessed 13 Sept 2019."},{"issue":"649","key":"3812_CR23","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3399\/bjgp16X686221","volume":"66","author":"J Gabbay","year":"2016","unstructured":"Gabbay J, le May A. Mindlines: making sense of evidence in practice. Br J Gen Pract. 2016;66(649):402\u20133.","journal-title":"Br J Gen Pract"},{"issue":"2","key":"3812_CR24","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.cct.2013.08.008","volume":"36","author":"SS Sonnad","year":"2013","unstructured":"Sonnad SS, Mullins CD, Whicher D, Goldsack JC, Mohr PE, Tunis SR. Recommendations for the design of Phase 3 pharmaceutical trials that are more informative for patients, clinicians, and payers. Contemp Clin Trials. 2013;36(2):356\u201361.","journal-title":"Contemp Clin Trials"},{"key":"3812_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/1472-6963-7-125","volume":"7","author":"YJ Jansen","year":"2007","unstructured":"Jansen YJ, de Bont A, Foets M, Bruijnzeels M, Bal R. Tailoring intervention procedures to routine primary health care practice; an ethnographic process evaluation. BMC Health Serv Res. 2007;7:125.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"3812_CR26","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1186\/s13063-016-1546-3","volume":"17","author":"S Kalkman","year":"2016","unstructured":"Kalkman S, van Thiel GJ, Grobbee DE, Meinecke AK, Zuidgeest MG, van Delden JJ. Stakeholders\u2019 views on the ethical challenges of pragmatic trials investigating pharmaceutical drugs. Trials. 2016;17(1):419.","journal-title":"Trials."},{"issue":"4","key":"3812_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-013318","volume":"7","author":"H Pinnock","year":"2017","unstructured":"Pinnock H, Barwick M, Carpenter CR, Eldridge S, Grandes G, Griffiths CJ, et al. Standards for Reporting Implementation Studies (StaRI): explanation and elaboration document. BMJ Open. 2017;7(4):e013318.","journal-title":"BMJ Open"},{"issue":"1","key":"3812_CR28","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13063-018-2503-0","volume":"19","author":"B Candy","year":"2018","unstructured":"Candy B, Vickerstaff V, Jones L, King M. Description of complex interventions: analysis of changes in reporting in randomised trials since 2002. Trials. 2018;19(1):110.","journal-title":"Trials."},{"key":"3812_CR29","doi-asserted-by":"publisher","first-page":"g1687","DOI":"10.1136\/bmj.g1687","volume":"348","author":"TC Hoffmann","year":"2014","unstructured":"Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014;348:g1687 (Clinical research ed).","journal-title":"BMJ"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-019-3812-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-019-3812-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-019-3812-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T02:01:02Z","timestamp":1665194462000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-019-3812-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3812"],"URL":"https:\/\/doi.org\/10.1186\/s13063-019-3812-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.466\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.466\/v2","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"15 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval for this study was granted by the Queen Mary Research Ethics Committee (reference QMREC1360d). All participants provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"711"}}